Ronald D. Perrone

30.7k citations

128 papers · 12.0k indexed · 8 hit papers · h-index 42

Impact in

Nephrology top 0.05%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Renal Diseases and Glomerulopathies
Genetics top 0.1%
- Genetic and Kidney Cyst Diseases
- Genetic Syndromes and Imprinting

Papers in

Nephrology 45
- Renal Diseases and Glomerulopathies 26
- Dialysis and Renal Disease Management 16
Genetics 96
- Genetic and Kidney Cyst Diseases 94
- Genetic Syndromes and Imprinting 19

Co-authors: Andrew S. Levey Nicolaos E. Madias Josef Coresh Joseph T. F. Lau Adeera Levin Ethan M. Balk Ronald J. Hogg Garabed Eknoyan
Journals: American Journal of Kidney Diseases (17 papers)Clinical Journal of the American Society of Nephrology (13 papers)Kidney International Reports (12 papers)Journal of the American Society of Nephrology (10 papers)Kidney International (7 papers)
Partner nations: United States Netherlands Canada

In The Last Decade

Ronald D. Perrone

126 papers receiving 11.7k citations

Hit Papers

8 papers align trajectories log scale

Autosomal dominant polycystic kidney disease 2019 · 351 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 The Lancet
2017 New England Journal of Medicine
2015 Kidney International
2014 New England Journal of Medicine
2012 New England Journal of Medicine
2003 Annals of Internal Medicine
1992 Clinical Chemistry
1988 Annual Review of Medicine

Peers

Countries citing papers authored by Ronald D. Perrone

Since Specialization

Citations

This map shows the geographic impact of Ronald D. Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald D. Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald D. Perrone more than expected).

Fields of papers citing papers by Ronald D. Perrone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald D. Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald D. Perrone. The network helps show where Ronald D. Perrone may publish in the future.

Co-authors

The 25 scholars most cited alongside Ronald D. Perrone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald D. Perrone Line = papers co-authored together Ronald D. Perrone links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pain and Health-Related Quality of Life in Autosomal Dominant Polycystic Kidney Disease: Results from a National Patient-Powered Registry Kidney Medicine ·Armstrong Ma, S. Kadelbach, Julian Howard Taylor, Dorothee Oberdhan, Ronald D. Perrone, Ciane Christine Alves de Moraes, Meyeon Park, Milind A. Phadnis, E. Sawaguchi, Neera K. Dahl	2024	2
2	An Unusually Prolonged Case of FGF23-mediated Hypophosphatemia Secondary to Ferric Carboxymaltose Use JCEM Case Reports ·صلاح حسن هاشم, Ina Shehaj, Ronald D. Perrone, Lisa Ceglia	2023	3
3	Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial American Journal of Kidney Diseases ·Ronald T. Gansevoort, Ali Hariri, Pascal Minini, Curie Ahn, Arlene B. Chapman, Shigeo Horie, Bertrand Knebelmann, Michal Mrug, Albert Ong, York Pei, Vicente E. Torres, Vijay Modur, Yassin Dia, Ronald D. Perrone	2022	12
4	The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial Journal of the American Society of Nephrology ·Pierluigi Russo, Ron T. Gansevoort, Vicente E. Torres, Olivier Devuyst, Ronald D. Perrone, Jennifer Lee, Hui Li, John Ouyang, Arlene B. Chapman	2021	7
5	PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies Kidney International Reports ·Janusz Strzyzewsky, Zhiying You, Berenice Y. Gitomer, Godela Brosnahan, Kaleab Z. Abebe, William E. Braun, Arlene B. Chapman, Peter C. Harris, Ronald D. Perrone, Theodore I. Steinman, Vicente E. Torres, Alan S.L. Yu, Michel Chonchol, Kristen L. Nowak	2021	5
6	Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease Kidney International ·Katharina Hopp, Émilie Cornec-Le Gall, Sarah R. Senum, Iris te Paske, Jeffrey Pilla, Sravanthi Lavu, Saurabh Baheti, Marie E. Edwards, Charles D. Madsen, Christina M. Heyer, Albert Ong, Kyongtae T. Bae, Richard Fatica, Theodore I. Steinman, Arlene B. Chapman, Berenice Y. Gitomer, Ronald D. Perrone, Frederic F. Rahbari-Oskoui, Vicente E. Torres, Peter C. Harris	2019	49
7	Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease Kidney International ·Ron T. Gansevoort, Maatje D.A. van Gastel, Arlene B. Chapman, Jaime D. Blais, Frank S. Czerwiec, Eiji Higashihara, Jennifer Lee, John Ouyang, Ronald D. Perrone, Y. Chen, Vicente E. Torres, Olivier Devuyst	2019	54
8	A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease American Journal of Nephrology ·Stephen L. Seliger, Kaleab Z. Abebe, Kenneth R. Hallows, Dana C. Miskulin, Ronald D. Perrone, Terry Watnick, Kyongtae T. Bae	2018	50
9	Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease American Journal of Nephrology ·Vicente E. Torres, Olivier Devuyst, Arlene B. Chapman, Ron T. Gansevoort, Ronald D. Perrone, John Ouyang, Jaime D. Blais, Frank S. Czerwiec, Olga Sergeyeva, (unknown)	2017	18
10	Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial Journal of the American Society of Nephrology ·Olivier Devuyst, Arlene B. Chapman, Ron T. Gansevoort, Eiji Higashihara, Ronald D. Perrone, Vicente E. Torres, Jaime D. Blais, Wen Zhou, John Ouyang, Frank S. Czerwiec	2016	65
11	Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled Trial American Journal of Kidney Diseases ·Niek F. Casteleijn, Jaime D. Blais, Arlene B. Chapman, Frank S. Czerwiec, Olivier Devuyst, Eiji Higashihara, Anna M. Leliveld, John Ouyang, Ronald D. Perrone, Vicente E. Torres, Ron T. Gansevoort	2016	29
12	Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data ClinicoEconomics and Outcomes Research ·Tyler Knight, Caroline Schaefer, Holly B. Krasa, Dorothee Oberdhan, Arlene B. Chapman, Ronald D. Perrone	2015	21
13	Left Ventricular Hypertrophy in ADPKD: Changing Demographics Current Hypertension Reviews ·Ahsan Alam, Ronald D. Perrone	2013	20
14	Patient-Reported Outcomes in Clinical Trials of CKD-Related Therapies: Report of a Symposium Sponsored by the National Kidney Foundation and the US Food and Drug Administration American Journal of Kidney Diseases ·Ronald D. Perrone, Stephen Joel Coons, Kerri L. Cavanaugh, Fred Finkelstein, Klemens B. Meyer	2013	33
15	Maintenance Immunosuppression with Intermittent Intravenous IL-2 Receptor Antibody Therapy in Renal Transplant Recipients Annals of Pharmacotherapy ·Steven Gabardi, K PRINS, Spencer T. Martin, Ronald D. Perrone, Anil Chandraker, Colm Magee, Rania Mosad	2011	5
16	Tissue-Engineered Three-Dimensional In Vitro Models for Normal and Diseased Kidney Tissue Engineering Part A ·Balajikarthick Subramanian, D. Rudym, yael shimoni shilo, Ronald D. Perrone, Jing Zhou, David L. Kaplan	2010	75
17	The HALT Polycystic Kidney Disease Trials Clinical Journal of the American Society of Nephrology ·Arlene B. Chapman, Vicente E. Torres, Ronald D. Perrone, Theodore I. Steinman, Kyongtae T. Bae, J. Philip Miller, Dana C. Miskulin, Frederic F. Rahbari-Oskoui, Amirali Masoumi, Marie C. Hogan, Franz T. Winklhofer, William E. Braun, Paul A. Thompson, Catherine M. Meyers, Klaus Deimel, Robert W. Schrier	2010	102
18	Effects of Fish Oil Supplementation on Kidney Transplantation Journal of the American Society of Nephrology ·Athina Tatsioni, Mei Chung, G. Szendrey, Bruce Kupelnick, Alice H. Lichtenstein, Ronald D. Perrone, Priscilla Chew, Joseph T. F. Lau, Peter A Bonis	2005	30
19	National Kidney Foundation Practice Guidelines for Chronic Kidney Disease Annals of Internal Medicine ·Andrew S. Levey, Josef Coresh, Ethan M. Balk, Annamaria T. Kausz, Adeera Levin, Michael W. Steffes, Ronald J. Hogg, Ronald D. Perrone, Joseph T. F. Lau, Garabed Eknoyan, Kerry Willis	2003	48
20	Serum Creatinine and Renal Function Annual Review of Medicine ·Andrew S. Levey, Ronald D. Perrone, Nicolaos E. Madias Hit paper breakdown →	1988	451

About Ronald D. Perrone

Ronald D. Perrone is a scholar working on Nephrology, Genetics, Pediatrics, Perinatology and Child Health, Pathology and Forensic Medicine and Molecular Biology, having authored 128 papers that have together received 12.0k indexed citations. Recurring topics across this work include Genetic and Kidney Cyst Diseases (94 papers), Renal and related cancers (40 papers), Renal Diseases and Glomerulopathies (26 papers), Biomedical Research and Pathophysiology (20 papers), Genetic Syndromes and Imprinting (19 papers), Dialysis and Renal Disease Management (16 papers), Pediatric Urology and Nephrology Studies (16 papers) and Ion Transport and Channel Regulation (14 papers). The work is most often cited by research in Nephrology (4.4k citations), Genetics (4.7k citations), Transplantation (320 citations), Pathology and Forensic Medicine (1.6k citations) and Pediatrics, Perinatology and Child Health (1.5k citations). Ronald D. Perrone has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Andrew S. Levey, Nicolaos E. Madias, Josef Coresh, Joseph T. F. Lau, Adeera Levin, Ethan M. Balk, Ronald J. Hogg, Garabed Eknoyan, Annamaria T. Kausz and Michael W. Steffes. Their work appears in journals such as American Journal of Kidney Diseases, Clinical Journal of the American Society of Nephrology, Kidney International Reports, Journal of the American Society of Nephrology and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact